Granulation of hydrophobic powders: design and control of granule structure. This unique project will further enhance Australia's established world-class excellence in granulation research, and will assist in setting up a new school of excellence in granulation at Monash University. The innovative use of normally problematic material properties to produce 'designer granules' is a clear example of a 'Frontier Technologies' that can be used to develop 'Advanced Materials' for the next generation o ....Granulation of hydrophobic powders: design and control of granule structure. This unique project will further enhance Australia's established world-class excellence in granulation research, and will assist in setting up a new school of excellence in granulation at Monash University. The innovative use of normally problematic material properties to produce 'designer granules' is a clear example of a 'Frontier Technologies' that can be used to develop 'Advanced Materials' for the next generation of agricultural, food and pharmaceutical industries, particularly for delivery of hydrophobic drugs. The innovative ideas presented in this proposal are expected to provide multiple opportunities for collaboration with national and international research institutions and pharmaceutical companies. Read moreRead less
Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a p ....Jet breakup of emulsions for the production of designer microparticulate drug delivery systems. Drug delivery systems are an important and growing part of the pharmaceutical and biotechnology market. The growth is estimated to be at 23% p.a. and is tied to the requirements for more precise and complex delivery profiles by highly potent drugs or vaccines (bioactives). To achieve the required level of control and precision, improved encapsulation technologies are needed to produce particles of a precise size and narrow size distribution. This project aims to develop an innovative technology for the production of superior uniformly sized particulate drug delivery systems for the delivery of the "next generation" bioactives.Read moreRead less